Breaking News & Top Stories
Recent calls for action emphasize the critical need for early detection of Alzheimer’s disease and related dementias, particularly in Virginia, where over 160,000 individuals are living with the condition. Advocacy…
UPDATE: The FDA has just announced a significant expansion in the approval of Addyi, a daily pill designed to boost libido, now available for postmenopausal women up to 65 years…
The Food and Drug Administration (FDA) has given its approval for the oral version of Novo Nordisk’s weight-loss medication, Wegovy, marking a significant milestone in obesity treatment. This decision, announced…
The Food and Drug Administration (FDA) has approved the oral version of Novo Nordisk’s weight loss medication, Wegovy. This marks the first time a GLP-1 pill has received regulatory clearance…
A recent call to action highlights the importance of enforcing existing laws regarding pets in food establishments. In a letter published on December 13, 2023, Michael Pravica emphasized that only…
Vancouver-based Clearmind Medicine Inc. has successfully completed the enrollment of six patients for the second cohort in its ongoing FDA-approved Phase I/IIa clinical trial of CMND-100, its proprietary drug candidate…
The U.S. Food and Drug Administration (FDA) has approved a daily pill designed to enhance libido among postmenopausal women, extending access to those up to the age of 65. This…
The U.S. Food and Drug Administration (FDA) has expanded the approval of the libido-boosting drug Addyi, allowing its use for women over the age of 65 who have undergone menopause.…
URGENT UPDATE: A nationwide recall has just been issued for a popular nasal spray due to confirmed microbial contamination, posing serious health risks to consumers. The announcement, made by the…
The recent decision by the CDC vaccine panel to cease recommending the birth dose of the Hepatitis B vaccine has sparked significant concern among health experts. Former FDA Commissioner Scott…